col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


88 Results       Page 1

 [1] 
Elsevier: Med
  original article Date Title Authors   All Authors
1 [GO] 2024―Mar―22 The central role of natural killer cells in mediating acute myocarditis after mRNA COVID-19 vaccination Hing Wai Tsang, Mike Yat Wah Kwan, Gilbert T. Chua, Sabrina Siu Ling Tsao, Joshua Sung Chih Wong, Keith Tsz Suen Tung, et al. (+5)
2 [GO] 2024―Feb―15 Complement dysregulation is a prevalent and therapeutically amenable feature of long COVID Kirsten Baillie, Helen E. Davies, Samuel B.K. Keat, Kristin Ladell, Kelly L. Miners, Samantha A. Jones, et al. (+5)
3 [GO] 2024―Feb―09 Olgotrelvir, a dual inhibitor of SARS-CoV-2 Mpro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19 Long Mao, Namir Shaabani, Xiaoying Zhang, Can Jin, Wanhong Xu, Christopher Argent, et al. (+35)
4 [GO] 2024―Jan―04 Olgotrelvir, a dual inhibitor of SARS-CoV-2 Mpro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19 Long Mao, Namir Shaabani, Xiaoying Zhang, Can Jin, Wanhong Xu, Christopher Argent, et al. (+35)
5 [GO] 2023―Sep―27 Ancestral, Delta, and Omicron (BA.1) SARS-CoV-2 strains are dependent on serine proteases for entry throughout the human respiratory tract Matthew J. Gartner, Leo Yi Yang Lee, Francesca L. Mordant, Randy Suryadinata, Joseph Chen, Philip Robinson, et al. (+2)
6 [GO] 2023―Sep―21 A multi-country analysis of COVID-19 hospitalizations by vaccination status Bronner P. Gonçalves, Waasila Jassat, Joaquín Baruch, Madiha Hashmi, Amanda Rojek, Abhishek Dasgupta, et al. (+473)
7 [GO] 2023―Sep―07 Multidrug-resistant mutations to antiviral and antibody therapy in an immunocompromised patient infected with SARS-CoV-2 Yosuke Hirotsu, Hiroaki Kobayashi, Yumiko Kakizaki, Akitoshi Saito, Toshiharu Tsutsui, Makoto Kawaguchi, et al. (+6)
8 [GO] 2023―Jul―08 SARS-CoV-2 niches in human placenta revealed by spatial transcriptomics Enrico R. Barrozo, Maxim D. Seferovic, Eumenia C.C. Castro, Angela M. Major, David N. Moorshead, Michael D. Jochum, et al. (+3)
9 [GO] 2023―Feb―13 Cost-effectiveness of fractional doses of COVID-19 vaccine boosters in India Zhanwei Du, Lin Wang, Yuan Bai, Shuo Feng, Sabareesh Ramachandran, Wey Wen Lim, et al. (+3)
10 [GO] 2022―Oct―20 Evidence for SARS-CoV-2 Delta and Omicron co-infections and recombination Alexandre Bolze, Tracy Basler, Simon White, Andrew Dei Rossi, Dana Wyman, Hang Dai, et al. (+24)
11 [GO] 2022―Oct―05 Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without Omicron breakthrough infection Delphine Planas, Isabelle Staropoli, Françoise Porot, Florence Guivel-Benhassine, Lynda Handala, Matthieu Prot, et al. (+11)
12 [GO] 2022―Sep―22 Data-driven COVID-19 policy is more effective than a one-size-fits-all approach Zoë M. McLaren
13 [GO] 2022―Sep―19 Multimodal surveillance of SARS-CoV-2 at a university enables development of a robust outbreak response framework Brittany A. Petros, Jillian S. Paull, Christopher H. Tomkins-Tinch, Bryn C. Loftness, Katherine C. DeRuff, Parvathy Nair, et al. (+58)
14 [GO] 2022―Aug―12 Lessons from an international trial evaluating vaccination strategies for recovered inpatients with COVID-19 (VATICO) Eleftherios Mylonakis, Joseph Lutaakome, Mamta K. Jain, Angela J. Rogers, José Moltó, Susana Benet, et al. (+26)
15 [GO] 2022―Aug―08 Discovery and Intranasal Administration of a SARS-CoV-2 Broadly-Acting Neutralizing Antibody with Activity against multiple Omicron sub variants J. Andrew Duty, Thomas Kraus, Heyue Zhou, Yanliang Zhang, Namir Shaabani, Soner Yildiz, et al. (+43)
16 [GO] 2022―Aug―08 Monitoring of the SARS-CoV-2 Omicron BA.1/BA.2 lineage transition in the Swedish population reveals increased viral RNA levels in BA.2 cases Antonio Lentini, Antonio Pereira, Ola Winqvist, Björn Reinius
17 [GO] 2022―Jun―10 Longitudinal sampling sheds light on SARS-CoV-2 fecal shedding dynamics Michael P. Coryell, Paul E. Carlson
18 [GO] 2022―Jun―09 Association of neutralizing breadth against SARS-CoV-2 with inoculation orders of heterologous prime-boost vaccines Yufang Zhu, Yingying Lu, Caili Zhou, Gangling Tong, Manman Gao, Yan Zhan, et al. (+20)
19 [GO] 2022―May―19 B-cell-derived cfDNA after primary BNT162b2 mRNA vaccination anticipates memory B-cells and SARS-CoV-2 neutralizing antibodies Ilana Fox-Fisher, Sheina Piyanzin, Mayan Briller, Esther Oiknine-Djian, Or Alfi, Roni Ben-Ami, et al. (+21)
20 [GO] 2022―May―16 Chemosensory losses in past and active likely Delta variant break-through COVID-19 cases Kym Man, Christopher T. Simons, Aayah Mohamed-Osman, Susan P. Travers, Kai Zhao
21 [GO] 2022―Apr―26 Safety and immunogenicity of the Pfizer/BioNTech SARS-CoV-2 mRNA third booster vaccine dose against the SARS-CoV-2 BA.1 and BA.2 Omicron variants Yohei Seki, Yasuo Yoshihara, Kiyoko Nojima, Haruka Momose, Shuetsu Fukushi, Saya Moriyama, et al. (+10)
22 [GO] 2022―Apr―15 mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2 Tamarand L. Darling, Baoling Ying, Bradley Whitener, Laura A. VanBlargan, Traci L. Bricker, Chieh-Yu Liang, et al. (+11)
23 [GO] 2022―Apr―14 Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, beta, delta, and omicron variants Arinjay Banerjee, Jocelyne Lew, Andrea Kroeker, Kaushal Baid, Patryk Aftanas, Kuganya Nirmalarajah, et al. (+17)
24 [GO] 2022―Apr―13 Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection Aravind Natarajan, Soumaya Zlitni, Erin F. Brooks, Summer E. Vance, Alex Dahlen, Haley Hedlin, et al. (+12)
25 [GO] 2022―Apr―06 Rapid emergence of SARS-CoV-2 Omicron variant is associated with an infection advantage over Delta in vaccinated persons Chrispin Chaguza, Andreas Coppi, Rebecca Earnest, David Ferguson, Nicholas Kerantzas, Frederick Warner, et al. (+20)
26 [GO] 2022―Mar―17 Reduced Pathogenicity of the SARS-CoV-2 Omicron Variant in Hamsters Katherine McMahan, Victoria Giffin, Lisa H. Tostanoski, Benjamin Chung, Mazuba Siamatu, Mehul S. Suthar, et al. (+10)
27 [GO] 2022―Mar―11 A randomized, double-blind, placebo-controlled trial of intravenous alpha-1 antitrypsin for acute respiratory distress syndrome secondary to COVID-19 Oliver J. McElvaney, Natalie L. McEvoy, Fiona Boland, Oisín F. McElvaney, Grace Hogan, Karen Donnelly, et al. (+21)
28 [GO] 2022―Mar―11 Engineering monoclonal antibodies for COVID-19 prophylaxis Amin Izadpanah, Jay Rappaport
29 [GO] 2022―Mar―04 Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants Sho Miyamoto, Takeshi Arashiro, Yu Adachi, Saya Moriyama, Hitomi Kinoshita, Takayuki Kanno, et al. (+30)
30 [GO] 2022―Feb―11 Integrated testing for TB and COVID-19 Emily L. MacLean, Luz Villa-Castillo, Morten Ruhwald, César Ugarte-Gil, Madhukar Pai
31 [GO] 2022―Feb―03 A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in cynomolgus macaques Ronald R. Cobb, Joseph Nkolola, Pavlo Gilchuk, Abishek Chandrashekar, Jingyou Yu, Robert V. House, et al. (+20)
32 [GO] 2022―Jan―31 Antiviral metabolite 3'-Deoxy-3',4'-didehydro-cytidine is detectable in serum and identifies acute viral infections including COVID-19 Ravi Mehta, Elena Chekmeneva, Heather Jackson, Caroline Sands, Ewurabena Mills, Dominique Arancon, et al. (+12)
33 [GO] 2022―Jan―20 Salivary IgG to SARS-CoV-2 indicates seroconversion and correlates to serum neutralization in mRNA-vaccinated immunocompromised individuals Katie Healy, Elisa Pin, Puran Chen, Gunnar Söderdahl, Piotr Nowak, Stephan Mielke, et al. (+26)
34 [GO] 2021―Dec―11 Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infection Arjun Puranik, Patrick J. Lenehan, Eli Silvert, Michiel J.M. Niesen, Juan Corchado-Garcia, John C. O’Horo, et al. (+10)
35 [GO] 2021―Nov―18 Reduced antibody activity against SARS-CoV-2 B.1.617.2 Delta virus in serum of mRNA-vaccinated patients receiving Tumor Necrosis Factor-α inhibitors Rita E. Chen, Matthew J. Gorman, Daniel Y. Zhu, Juan Manuel Carreño, Dansu Yuan, Laura A. VanBlargan, et al. (+17)
36 [GO] 2021―Oct―12 Interferon gamma runs interference on persistent COVID-19 Eric Isaac Elliott, Andrew Wang
37 [GO] 2021―Sep―21 Interferon gamma immunotherapy in five critically ill COVID-19 patients with impaired cellular immunity: a case series Arjan van Laarhoven, Lisa Kurver, Gijs J. Overheul, Emma J. Kooistra, Wilson F. Abdo, Reinout van Crevel, et al. (+10)
38 [GO] 2021―Sep―10 Breathing more breadth into COVID-19 T cell responses David A. Bejarano, Andreas Schlitzer
39 [GO] 2021―Aug―14 Protective heterologous T cell immunity in COVID-19 induced by the trivalent Measles-Mumps-Rubella and Tetanus-Diptheria-Pertussis vaccine antigens Vijayashree Mysore, Xavier Cullere, Matthew L. Settles, Xinge Ji, Michael W. Kattan, Michaël Desjardins, et al. (+7)
40 [GO] 2021―Aug―14 Favourable antibody responses to human coronaviruses in children and adolescents with autoimmune rheumatic diseases Claire T. Deakin, Georgina H. Cornish, Kevin W. Ng, Nikhil Faulkner, William Bolland, Joshua Hope, et al. (+25)
41 [GO] 2021―Aug―14 A monocyte/dendritic cell molecular signature of SARS-CoV-2 related multisystem inflammatory syndrome in children (MIS-C) with severe myocarditis Camille de Cevins, Marine Luka, Nikaïa Smith, Sonia Meynier, Aude Magérus, Francesco Carbone, et al. (+44)
42 [GO] 2021―Jul―10 Why is COVID-19 associated with mental illness? Maxime Taquet, Paul J. Harrison
43 [GO] 2021―Jul―01 Real-time analysis of a mass vaccination effort confirms the safety of FDA-authorized mRNA COVID-19 vaccines Reid McMurry, Patrick Lenehan, Samir Awasthi, Eli Silvert, Arjun Puranik, Colin Pawlowski, et al. (+20)
44 [GO] 2021―Jun―29 FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system Colin Pawlowski, Patrick Lenehan, Arjun Puranik, Vineet Agarwal, A.J. Venkatakrishnan, Michiel J.M. Niesen, et al. (+6)
45 [GO] 2021―May―14 Advancing research in pregnancy during COVID-19: Missed opportunities and momentum in the US Elana F. Jaffe, Anne Drapkin Lyerly, Ilona T. Goldfarb
46 [GO] 2021―Apr―30 Maternal respiratory SARS-CoV-2 infection in pregnancy is associated with a robust inflammatory response at the maternal-fetal interface Alice Lu-Culligan, Arun R. Chavan, Pavithra Vijayakumar, Lina Irshaid, Edward M. Courchaine, Kristin M. Milano, et al. (+25)
47 [GO] 2021―Apr―21 Rapid vaccination and partial lockdown minimizes 4th waves from emerging highly contagious SARS-CoV-2 variants Daniel B. Reeves, Chloe Bracis, David A. Swan, Eileen Burns, Mia Moore, Dobromir Dimitrov, Joshua T. Schiffer
48 [GO] 2021―Apr―15 Mucosal Associated Invariant T (MAIT) Cell Responses Differ by Sex in COVID-19 Chen Yu, Sejiro Littleton, Nicholas S. Giroux, Rose Mathew, Shengli Ding, Joan Kalnitsky, et al. (+15)
49 [GO] 2021―Apr―15 SARS-CoV-2 colonization of maternal and fetal cells of the human placenta promotes alteration of local renin-angiotensin system Sonam Verma, Chetanchandra S. Joshi, Rachel B. Silverstein, Mai He, Ebony B. Carter, Indira U. Mysorekar
50 [GO] 2021―Apr―09 How did Jordan combat COVID-19: Lessons learned for scaling Akeel T. Al-Kazwini, Walid Al-Zyoud, Samira Al-Nasser, Salem A. Alswaiti, Dalia S. Khankan, Rana Dajani
51 [GO] 2021―Apr―08 Understanding Vaccine Hesitancy in COVID-19 Brit Trogen, Liise-anne Pirofski
52 [GO] 2021―Apr―08 Early T cell and binding antibody responses are associated with Covid-19 RNA vaccine efficacy onset Shirin Kalimuddin, Christine YL. Tham, Martin Qui, Ruklanthi de Alwis, Jean XY. Sim, Joey ME. Lim, et al. (+11)
53 [GO] 2021―Apr―03 A Public Health Antibody Screening Indicates a Marked Increase of SARS-CoV-2 Exposure Rate in Children during the Second Wave Markus Hippich, Philipp Sifft, Jose Zapardiel-Gonzalo, Merle M. Böhmer, Vito Lampasona, Ezio Bonifacio, Anette-Gabriele Ziegler
54 [GO] 2021―Apr―01 Alterations in T and B cell function persist in convalescent COVID-19 patients Halima A. Shuwa, Tovah N. Shaw, Sean B. Knight, Kelly Wemyss, Flora A. McClure, Laurence Pearmain, et al. (+17)
55 [GO] 2021―Apr―01 Simultaneous Detection and Mutation Surveillance of SARS-CoV-2 and co-infections of multiple respiratory viruses by Rapid field-deployable sequencing Chongwei Bi, Gerardo Ramos-Mandujano, Yeteng Tian, Sharif Hala, Jinna Xu, Sara Mfarrej, et al. (+9)
56 [GO] 2021―Mar―25 Defining long COVID: Going back to the start Nisreen A. Alwan, Luke Johnson
57 [GO] 2021―Mar―20 Achieving Path-Dependent Equity for Global COVID-19 Vaccine Allocation Anthony D. So, Joshua Woo
58 [GO] 2021―Mar―07 Can COVID-19 innovations and systems help low- and middle-income countries to re-imagine healthcare delivery? Senjuti Saha, Madhukar Pai
59 [GO] 2021―Feb―27 A clinician’s primer on epidemiology for COVID-19 Azman Rashid, Karla Therese L. Sy, Jacob M. Cabrejas, Brooke E. Nichols, Nahid Bhadelia, Eleanor J. Murray
60 [GO] 2021―Feb―24 Deadly COVID-19 Among the Elderly: Innate Immune Memory Helping those Most in Need Yahya Sohrabi, Holger Reineceke, Leo A.B. Joosten, Mihai G. Netea
61 [GO] 2021―Feb―16 Virtual Undergraduate Research Experiences: More Than a Pandemic Stopgap Tahoura Samad, Heather E. Fleming, Sangeeta N. Bhatia
62 [GO] 2021―Feb―10 Persistence of SARS-CoV-2 specific B- and T-cell responses in convalescent COVID-19 patients 6-8 months after the infection Natalia Sherina, Antonio Piralla, Likun Du, Hui Wan, Makiko Kumagai-Braesch, Juni Andréll, et al. (+25)
63 [GO] 2021―Jan―31 Stable neutralizing antibody levels six months after mild and severe COVID-19 episode Edwards Pradenas, Benjamin Trinité, Víctor Urrea, Silvia Marfil, Carlos Ávila-Nieto, María Luisa Rodríguez de la Concepción, et al. (+17)
64 [GO] 2021―Jan―18 Cell-Free DNA Tissues-of-Origin by Methylation Profiling Reveals Significant Cell, Tissue and Organ-Specific injury related to COVID-19 Severity Alexandre Pellan Cheng, Matthew Pellan Cheng, Wei Gu, Joan Sesing Lenz, Elaine Hsu, Erwin Schurr, et al. (+7)
65 [GO] 2021―Jan―12 Development and Validation of a Risk Score Using Complete Blood Count to Predict In-hospital Mortality in COVID-19 Patients Hui Liu, Jing Chen, Qin Yang, Fang Lei, Changjiang Zhang, Juan-Juan Qin, et al. (+31)
66 [GO] 2020―Dec―26 SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity Chantal B.F. Vogels, Anne E. Watkins, Christina A. Harden, Doug E. Brackney, Jared Shafer, Jianhui Wang, et al. (+27)
67 [GO] 2020―Dec―18 The Assessment of Convalescent Plasma Efficacy against COVID-19 Arturo Casadevall, Brenda J. Grossman, Jeffrey P. Henderson, Michael J. Joyner, Shmuel Shoham, Liise-anne Pirofski, Nigel Paneth
68 [GO] 2020―Dec―18 The Global Response to the COVID-19 Pandemic John Nkengasong, Akiko Iwasaki, Cesar Victora, Juhwan Oh, George F. Gao, Anurag Agrawal, et al. (+6)
69 [GO] 2020―Dec―18 Life-Threatening COVID-19: Defective Interferons Unleash Excessive Inflammation Qian Zhang, Paul Bastard, Alexandre Bolze, Emmanuelle Jouanguy, Shen-Ying Zhang, Aurélie Cobat, et al. (+4)
70 [GO] 2020―Dec―18 SARS-CoV-2 Re-infections: Lessons from Other Coronaviruses Lia van der Hoek
71 [GO] 2020―Dec―17 Uniting infectious disease and physical science principles on the importance of face masks for COVID-19 Monica Gandhi, Linsey C. Marr
72 [GO] 2020―Dec―17 A booster dose enhances immunogenicity of the COVID-19 vaccine candidate ChAdOx1 nCoV-19 in aged mice Alyssa Silva-Cayetano, William S. Foster, Silvia Innocentin, Sandra Belij-Rammerstorfer, Alexandra J. Spencer, Oliver T. Burton, et al. (+13)
73 [GO] 2020―Dec―05 Pandemic vaccines: How are we going to be better prepared next time? Florian Krammer
74 [GO] 2020―Dec―03 The potential for repurposing anti-TNF as a therapy for the treatment of COVID-19 Philip C. Robinson, David F.L. Liew, Jean W. Liew, Claudia Monaco, Duncan Richards, Senthuran Shivakumar, et al. (+2)
75 [GO] 2020―Oct―30 Public health antibody screening indicates a six-fold higher SARS-CoV-2 exposure rate than reported cases in children Markus Hippich, Lisa Holthaus, Robin Assfalg, Jose M. Zapardiel Gonzalo, Heidi Kapfelsperger, Martin Heigermoser, et al. (+17)
76 [GO] 2020―Oct―10 A prediction model to prioritize individuals for SARS-CoV-2 test built from national symptom surveys Saar Shoer, Tal Karady, Ayya Keshet, Smadar Shilo, Hagai Rossman, Amir Gavrieli, et al. (+19)
77 [GO] 2020―Oct―02 Kidney function indicators predict adverse outcomes of COVID-19 Ye-Mao Liu, Jing Xie, Ming-Ming Chen, Xiao Zhang, Xu Cheng, Haomiao Li, et al. (+22)
78 [GO] 2020―Aug―21 The Interpretation of SARS-CoV-2 Diagnostic Tests Edward C. Stites, Craig B. Wilen
79 [GO] 2020―Jul―21 Virus-host interactome and proteomic survey of PBMCs from COVID-19 patients reveal potential virulence factors influencing SARS-CoV-2 pathogenesis Jingjiao Li, Mingquan Guo, Xiaoxu Tian, Xin Wang, Xing Yang, Ping Wu, et al. (+11)
80 [GO] 2020―Jul―04 Deficiencies in the designs and interventions of COVID-19 clinical trials David Hsiehchen, Magdalena Espinoza, Antony Hsieh
81 [GO] 2020―Jun―29 When two pandemics meet: Why is obesity associated with increased COVID-19 mortality? Sam M. Lockhart, Stephen O’Rahilly
82 [GO] 2020―Jun―19 Regulatory and safety considerations in deploying a locally fabricated, reusable, face shield in a hospital responding to the COVID-19 pandemic Arash Mostaghimi, Marc-Joseph Antonini, Deborah Plana, Philip D. Anderson, Brandon Beller, Edward W. Boyer, et al. (+10)
83 [GO] 2020―Jun―06 SARS-Cov2 Clinical Diagnostics: Academic Scientists Take on the COVID-19 Pandemic Fyodor Urnov
84 [GO] 2020―Jun―05 Outcomes of hydroxychloroquine usage in United States veterans hospitalized with COVID-19 Joseph Magagnoli, Siddharth Narendran, Felipe Pereira, Tammy H. Cummings, James W. Hardin, S. Scott Sutton, Jayakrishna Ambati
85 [GO] 2020―May―19 Validation of predictors of disease severity and outcomes in COVID-19 patients: a descriptive and retrospective study Li Tan, Xia Kang, Xinran Ji, Gaoming Li, Qi Wang, Yongsheng Li, et al. (+2)
86 [GO] 2020―May―19 Efficacy and safety of lopinavir/ritonavir or arbidol in adult patients with mild/moderate COVID-19: an exploratory randomized controlled trial Yueping Li, Zhiwei Xie, Weiyin Lin, Weiping Cai, Chunyan Wen, Yujuan Guan, et al. (+14)
87 [GO] 2020―May―19 What is the best drug to treat COVID-19? The need for randomized controlled trials Silvia Ottaviani, Justin Stebbing
88 [GO] 2020―May―19 Rapid Implementation of a SARS-CoV-2 Diagnostic qRT-PCR Test with Emergency Use Authorization at a Large Academic Safety-Net Hospital Kim Vanuytsel, Aditya Mithal, Richard M. Giadone, Anthony K. Yeung, Taylor M. Matte, Todd W. Dowrey, et al. (+5)
 [1] 

88 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec